In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Dr. Paolo Zola to discuss the TOTEM trial. For 20 years, Dr. Zola has been Chair of Gynaecological Oncology in the Department of Surgical Sciences of the University of Turin (Italy). Dr. Zola has conducted a large number of national and international randomized clinical trials in order to optimize the treatments for women diagnosed with gynaecological cancers. He has served as a member of the board of the EORTC Gynaecological Cancer Group and of the ESGO. Dr. Zola chairs the gynaecological cooperative group within the Oncological Network in Piedmont Region, and his research has been reported in more than 400 manuscripts published in peer reviewed literature.



Highlights:

- To perform the follow up in patients treated for endometrial cancer, the cornerstone is the clinical control.
- In low-risk patients, surveillance every 6 months is appropriate.
- In high-risk patients a clinical examination every 4 months for 2 years and then every 6 is recommended.
- In addition, our data suggest taking a CT after 12 and 20 months after the primary treatment.